UNAIDS: Declining investment could slow research and rollout of new HIV prevention options
“Investment in HIV prevention research fell US$50 million, or four percent, to US$1.26 billion in 2013, due to declining investments by the United States and European government donors, changes in the international development landscape, and changes in the pipeline of HIV prevention products in various stages of development and implementation, according to a new report from the HIV Vaccines and Microbicides Resource Tracking Working Group…” (7/18).